In a press release, the CHU of Nice and Eurobiomed announced the selection of the first Experimental Skin Health Hub, a project funded by the French government as part of the Digital Health Acceleration Strategy under the France 2030 plan.
- This hub, focused on dermatological diseases, benefits from a total budget of €63 million over five years, allocated across all initiatives within the program.
- Its aim is to address the needs of 20 million French citizens suffering from skin conditions, leveraging digital technologies to improve diagnosis and access to care.
- The initial projects will involve up to 6,000 patients in the Provence-Alpes-Côte d’Azur and Corsica regions, paving the way for the future Skin Institute, set to open in Nice.
A Hub to Transform Dermatology
Approved during the National Digital Health Innovation Day, the Skin Experimental Hub is a collaborative initiative bringing together healthcare professionals, researchers, companies, and associations Located in the south of France, it will enable the testing of solutions such as medical image analysis for faster and more accurate diagnoses.
The Skin Experimental Hub is an innovative program where healthcare professionals, businesses, researchers, and patient associations collaborate to test and validate new digital solutions in dermatology. Deployed in the Provence-Alpes-Côte d’Azur and Corsica regions, it plans to include up to 6,000 patients in its initial experimental projects.
The solutions developed will focus on analyzing various types of medical images to facilitate patient diagnosis and follow-up. This project will ultimately culminate in the establishment of the future Skin Institute, a physical site that will open in Nice in the coming years.
“This hub represents a unique opportunity to significantly enhance the management of skin diseases,” said Professor Thierry Passeron, Head of Dermatology at the CHU of Nice and project lead. “By combining medical expertise with digital technologies, we will offer faster and more accurate diagnostics without invasive procedures. These technologies should also improve access to dermatological diagnosis and care, particularly benefiting patients in areas where access to dermatologists is limited.”
The Skin Experimental Hub perfectly exemplifies our mission to unite and support large public-private projects that drive tomorrow’s health innovations,” emphasized Emilie Royère, CEO of Eurobiomed. “We invite all stakeholders to the first Skin Summit in Antibes in April 2025, which will bring together experts and innovators to discuss the latest advancements in dermatology.”
A Structuring Collaboration
Supported by the Region, the Regional Health Agency (ARS), and their partners, this program is part of an innovation strategy to advance digital health.
Health Nice Côte d’Azur
- The Nice University Hospital performs its 100th liver transplantation since 2024
- Obesity: French first at Nice University Hospital
- Team Nice Côte d’Azur at the Van Lanschot Kempen Life Sciences Conference 2026
- Launch of the AZUR Territorial Research Entity to advance clinical research on the French Riviera
- BIO-Europe Spring 2026 : meet with Team Nice Côte d’Azur
- Eurobiomed: more than €300 million secured in 2025 in the Sud and Occitanie regions by Eurobiomed member healthcare companies
- Artificial intelligence: Team Nice Côte d’Azur mobilized for an AI Business Tour and WAICF 2026
- Nice University Hospital signs an international cooperation agreement with Emirates Hospitals Group (Dubai)
- Caranx Medical, a Nice-based cardiac robotics MedTech startup, set to be acquired for €16.6 million
- AVC continues its expansion with a consolidated base in the Côte d’Azur
